Burning Rock Biotech Limited (BNR) Volatility Skew
Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.
Burning Rock Biotech Limited (BNR) operates in the Healthcare sector, specifically the Medical - Diagnostics & Research industry, with a market capitalization near $14.0M, listed on NASDAQ, employing roughly 667 people, carrying a beta of 1.29 to the broader market. Headquartered in Guangzhou, China, and established in 2014, Burning Rock Biotech Limited is primarily engaged in developing and providing diagnostic solutions for cancer therapy selection within the People's Republic of China. Led by Yusheng Han, public since 2020-06-12.
Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for BNR as of 2026-11-22; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.
Learn how volatility skew is reported and how to read the data →